Advertisement

Science Translational Medicine

  • Volume 13
  • Issue 609
  • 01 Sep 2021
Go to Science Translational Medicine
Go to Science Translational Medicine

ONLINE COVER Minimizing Metastases. This scanning electron micrograph shows metastatic mouse tumor cells (in green) invading the lung parenchyma and stroma, in close contact with nearby capillaries (red). Singhal et al. studied the vascular niche after surgical resection of spontaneously metastasizing primary tumors in mice. Using transcriptomics and proteomics, they identified leucine-rich alpha-2 glycoprotein 1 (LRG1), produced by endothelial cells in response to tumor-induced inflammation, as a prometastatic molecule. Treatment with LRG1-neutralizing antibodies led to decreased metastatic burden and prolonged survival in these mice, suggesting that LRG1 may be a potential target to restrict metastatic tumor growth.[CREDIT: Eye of Science]

Advertisement

ABOUT

Science Translational Medicine is the leading weekly online journal publishing research at the intersection of science, engineering and medicine. The goal of Science Translational Medicine is to promote human health by providing a forum for communicating the latest research advances from biomedical, translational, and clinical researchers from all established and emerging disciplines relevant to medicine.

mission & scope

Advertisement

Podcasts

Advertisement

Advertisement